Archive for the ‘vaccines’ Category

A Bold Plan Against Lyme And Other Tick-borne Diseases

https://www.lymedisease.org/keber-ahern/

A bold plan against Lyme and other tick-borne diseases

tick that carried Lyme disease

By Barbara Keber, MD, and Holly Ahern

We need a national public-private strategy that abandons our current low-impact approach to diseases brought by ticks.

If you have not yet suffered with Lyme disease or one of the illnesses associated with the bite of a tick, you probably know someone who has — or who will. This growing public health threat requires a strong national response that advances research to improve prevention, diagnostic testing and treatment.

Specifically, we need a multibillion-dollar, national public-private partnership — an initiative that must address more than just Lyme disease and must go beyond the current low-impact strategy of telling the public to beware of ticks, wear white socks or shower after being outdoors.

The partnership should include federal agencies, pharmaceutical companies, state health departments, universities, laboratories and medical centers. And it should include patient representatives.

This is a serious threat. Diseases carried by ticks can cause life-altering disorders — joint and muscle pain, permanent neurological disorders, profound fatigue, memory loss, headaches and death. And the societal and treatment costs of these illnesses and lost productivity is in the billions.

Although Lyme disease is the most prevalent and best known of the various diseases ticks can transmit to humans, the Centers for Disease Control and Prevention lists at least 13 illnesses caused by ticks. The CDC has reported a dramatic increase in all tick-borne diseases.

Lyme disease cases have grown from the first identified case in 1975 to more than 300,000 new cases per year. Other tick-borne diseases have increased by more than six-fold between 2004 and 2017, from about 2,700 cases per year to more than 16,000. The CDC has acknowledged that “the United States is not fully prepared to control these threats.”

Three priorities

The first priority to prevent tick-related illnesses, regardless of cost, is to develop a vaccine against all tick-borne diseases.

A second priority is to improve diagnostic tests. Currently, treatment decisions hinge on the results of blood tests that more than 50 percent of the time can’t accurately identify patients who have Lyme disease, discriminate between active infection or past infection, or identify the presence of other tick-borne illnesses.

Based on the results of current blood tests, medications may not be prescribed to people that would be helpful, or they may be provided with unnecessary medications. From a health care perspective, this is unacceptable.

A third priority is to improve environmental control measures, such as more effective yet safe tick-killing products, repellents for humans and pets, and new approaches to landscape barriers that go beyond mulching the perimeter of one’s lawn.

Barriers include anything from fencing to keep out animals that carry ticks to anything that creates separation between wooded or high-grass areas and those areas where people play or work outdoors.

The Tick Borne Disease Working Group, created by the U.S. Department of Health and Human Services, submitted its report to the HHS secretary and Congress in December. Now, the public must demand that its recommendations — filling gaps in the areas of prevention, diagnosis, and treatment — be approved at a faster pace.

The occurrence and consequences of tick-borne diseases are increasing and this increase will continue unless we find big solutions to this big problem.

Barbara Keber, MD, practices family medicine in Glen Cove, NY, and is president of the New York State Academy of Family Physicians. Holly Ahern is an associate professor of microbiology at SUNY Adirondack, and was a member of the Testing and Diagnostic Subcommittee of the Tick Borne Disease Working Group.

________________

**Comment**

I’m extremely wary of the first priority outlined here of developing a vaccine against all tick-borne diseases “at all costs.” First, when you study how vaccines work, you understand they are created to evoke an immune response by causing inflammation. This is also what Lyme/MSIDS does.

It seems counter productive to me, a mere layman, to do both at the same time.

We are also armed with the knowledge that vaccines can activate latent infections. How many of the unsuspecting public have latent infections?  https://madisonarealymesupportgroup.com/2016/04/24/gardasil-and-bartonella/

https://madisonarealymesupportgroup.com/2017/12/02/scottish-doctor-gives-insight-on-lyme-msids/

Also, from my understanding, trying to hit all the variations, species, and subtypes of these pathogens would be akin to trying to create a vaccine for the flu, which is constantly changing and is a moving target. The flu vaccine is never effective: https://madisonarealymesupportgroup.com/2019/07/10/cdc-admits-flu-vaccine-failed-91-of-the-time-against-current-flu-strain/

https://madisonarealymesupportgroup.com/2018/10/23/influenza-vaccines-dengue-like-disease/

If we are serious about this pandemic, work should be gone into:
  • accurate testing
  • appropriate treatment
  • how it’s transmitted (congenital, breast milk, sexually, other bugs, etc)
  • how it survives (persistence)
  • how to make this affordable (getting insurance companies to pay)
  • the various ways it presents (symptomology)
  • doctor education
  • the synergistic effects of all the pathogens on the human body

Category:

Activism, Lyme, vaccines

What is Vaccine Shedding?

https://articles.mercola.com/sites/articles/archive/2019/07/23/what-is-vaccine-shedding.aspx?

What is vaccine shedding?

Analysis by Dr. Joseph MercolaFact Checked

July 23, 2019

vaccine shedding

STORY AT-A-GLANCE

  • Live viral vaccines contain a weakened (or attenuated) version of the virus
  • Live attenuated viral vaccines can cause vaccinated persons to shed vaccine strain virus for a period of days, weeks or months, potentially infecting others and leading to symptoms of the very disease the vaccine was intended to prevent
  • One recent study revealed not only that influenza virus may be spread via simple breathing (i.e., no sneezing or coughing required) but also that repeated vaccination increases the amount of virus released into the air
  • Individuals who had gotten a flu vaccination in the current and previous season had 6.3 times more aerosol shedding of influenza virus than those who had received no vaccination in those two seasons
  • Due to a lack of active surveillance and testing, there’s no way to know how often vaccine-strain live virus shedding and disease transmission actually occurs

When you’re infected with a virus that causes an illness, that virus is shed in your saliva and other bodily fluids, and sometimes also via skin lesions. This means that a person who comes into direct contact with the shed virus may also become infected. The same holds true for live attenuated viral vaccines.

While inactivated vaccines use a killed version of the pathogen, live viral vaccines use a weakened (or attenuated) version of the virus. Typically, the live virus used in vaccine production is passed through a living cell culture or other host, such as chicken embryo, many times over until it becomes weakened to a point that it’s not likely to make you sick when it’s injected or, in the case of live oral vaccines, swallowed.

That being said, a live vaccine strain virus is still active and strong enough to trigger an inflammatory response in your body, prompting the creation of vaccine-acquired antibodies. There are a few problems with this, such as the possibility that the weakened vaccine-strain virus can revert to virulence, leading to serious complications identical or similar to complications of the natural disease the vaccine is supposed to prevent in the vaccinated person.1

Another noted problem is that the person who is given a live attenuated viral vaccine can asymptomatically shed and transmit vaccine-strain virus for a period of days, weeks or months and potentially infect close contacts, who can also experience symptoms of the very disease the vaccine was intended to prevent.

Live flu vaccine associated with increased viral shedding in exhaled breath

The possibility of vaccine strain viral shedding takes on renewed importance in the case of the government’s strong recommendation for annual flu vaccination. The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommends annual influenza vaccinations for everyone 6 months and older.

In the 2018 to 2019 flu season, CDC officials recommended health care providers “use any licensed, age-appropriate influenza vaccine (inactivated influenza vaccines (IIV), recombinant influenza vaccine (RIV), or live attenuated influenza vaccine (LAIV4) with no preference expressed for one vaccine over another.”2

The live influenza vaccine FluMist, which is approved for nonpregnant women as well as anyone aged 2 to 49 years, is administered in the form of a nasal spray.

While the CDC states that the live type A and B vaccine strain influenza viruses in FluMist are too weak to actually give recipients influenza, research has raised some serious doubts that this is the case. One recent study revealed not only that influenza virus may be spread via simple breathing (i.e., no sneezing or coughing required) but also that repeated vaccination increases the amount of influenza virus released into the air.3

“Self-reported vaccination for the current season was associated with a trend toward higher viral shedding in fine-aerosol samples; vaccination with both the current and previous year’s seasonal vaccines, however, was significantly associated with greater fine-aerosol shedding … ,” the researchers stated.4

What’s more, individuals who had been vaccinated in the current and previous season had 6.3 times more aerosol shedding than those who had received no vaccination in those two seasons. The researchers concluded:5

“The association of current and prior year vaccination with increased shedding of influenza A might lead one to speculate that certain types of prior immunity promote lung inflammation, airway closure and aerosol generation … If confirmed, this observation, together with recent literature suggesting reduced protection with annual vaccination, would have implications for influenza vaccination recommendations and policies.”

Virus shedding is common following FluMist — and can transmit flu

MedImmune, the company that developed FluMist, is aware that the vaccine sheds vaccine-strain virus. In its prescribing information, they describe a study on the transmission of vaccine-strain influenza viruses from vaccinated children to nonvaccinated children in a day care setting.

In 80 percent of the FluMist recipients, at least one vaccine-strain influenza virus was isolated anywhere from one to 21 days following vaccination. They further noted, “One placebo subject had mild symptomatic Type B virus infection confirmed as a transmitted vaccine virus by a FluMist recipient in the same playgroup.”6

Another MedImmune study revealed that 89 percent of babies under 2 years who received FluMist shed vaccine-strain influenza virus, as did 20 percent of adults. The most virus was shed two to three days following vaccination, continuing for up to 11 days.7

While the CDC claims vaccine-strain virus shedding, and subsequent transmission of disease, is rare, they have also stated that people with a weakened immune system, or those who will be caring for someone with a weakened immune system within seven days of vaccination, should not receive the live attenuated influenza vaccine due to the “theoretical” risk that the recently vaccinated person could shed and transmit the vaccine-strain virus to immunocompromised individuals.

That being said, there’s no way to know for sure how often vaccine-strain live virus shedding and disease transmission actually occurs. Barbara Loe Fisher, cofounder and president of the National Vaccine Information Center (NVIC), wrote a special report, The Emerging Risks of Live Virus and Viral Vectored Vaccines: Vaccine Strain Virus Infection, Shedding and Transmission, which contains over 200 references and delves into virus shedding and vaccine virus shedding. She noted:8

“There is no active surveillance and testing for evidence of vaccine strain live virus shedding, transmission and infection among populations routinely being given multiple doses of live virus vaccines, including measles vaccine. Therefore, it is unknown exactly how many vaccinated children and adults in the U.S. or other countries are shedding and transmitting vaccine strain live viruses.

Whether or not vaccine strain live virus shedding, transmission and infection is causing undiagnosed or misdiagnosed health problems, especially among people with severe immune deficiencies or autoimmune and other immune system disorders, is an open question.”

Which vaccines are capable of shedding?

Examples of live attenuated viral vaccines are measles, mumps, rubella, vaccinia (smallpox), varicella, zoster (which contains the same virus as varicella vaccine but in much higher amount), yellow fever, rotavirus and influenza (intranasal).9 As with the live virus influenza vaccine, there are many examples of other live attenuated viral vaccines spreading disease.

The live oral polio vaccine (OPV) is one of them. OPV is no longer used in the U.S., having been replaced by inactivated injectable polio vaccine in 1999, but OPV is still used in some developing countries. In 2017, there were 21 reported cases of vaccine-derived polio, compared to six cases of wild polio — marking the first time more cases of polio were caused by vaccine-derived strains than wild or naturally occurring strains.

In Syria alone, 15 children were paralyzed by vaccine-derived polio, according to the World Health Organization (WHO).10 Research published in the journal Cell also revealed that the live vaccine strain virus used in the oral polio vaccine can easily mutate and spread through a community.11 NPR reported:12

“After a child is vaccinated with live polio virus, the virus replicates inside the child’s intestine and eventually is excreted. In places with poor sanitation, fecal matter can enter the drinking water supply and the virus is able to start spreading from person to person.

‘We discovered there’s only a few [mutations] that have to happen and they happen rather quickly in the first month or two post-vaccination,” [lead study author Raul] Andino says. ‘As the virus starts circulating in the community, it acquires further mutations that make it basically indistinguishable from the wild-type virus. It’s polio in terms of virulence and in terms of how the virus spreads.'”

WHO also noted, “When a child is immunized with OPV, the weakened vaccine virus replicates in the intestine for a limited period … During this time, the vaccine virus is also excreted.”13 In some people, however, the period of replication may not be so “limited.”

One British man received three doses of attenuated live virus polio vaccine at 5, 7 and 12 months of age. He also received a booster at age 7, as was recommended. The man has a health condition that suppresses his immune system, making it more difficult for him to clear vaccine-strain poliovirus from the body.

Although he had no symptoms of the disease, when researchers tested his stool (more than 100 samples were taken over a period of 28 years), they confirmed high levels of the poliovirus even decades later.

Virus shedding is also possible after MMR vaccination

The CDC recommends the MMR (measles, mumps and rubella) vaccine for children aged 12 to 15 months, with a booster between ages 4 and 6 years. This live attenuated combination vaccine has also been associated with vaccine-strain virus shedding and disease transmission.

For instance, following live virus measles vaccination, measles virus RNA was detected in 10 of 12 children, as early as one day or as late as 14 days after vaccination.14 Vaccine virus-related measles has also been documented, including in one 2-year-old boy who became ill 37 days after receiving an MMR vaccine.

The researchers who published the case report explained, “Although this is the first such reported case, it likely represents the existence of additional, but unidentified, exceptions to the typical timeframe for measles vaccine virus shedding and illness.”15

It’s often the case that measles outbreaks are blamed on unvaccinated individuals, but this suggests that recently vaccinated individuals could also transmit a vaccine strain version of the disease.

Likewise, mumps vaccine strain virus has also been confirmed as being transmitted by recently vaccinated children to their parents, while live rubella vaccine virus can be transmitted via breast milk. The live attenuated chickenpox vaccine can also cause vaccine-strain chickenpox in healthy or immunocompromised vaccine recipients — or their close contacts. According to Fisher:16

“It is possible for healthy children and adults to transmit vaccine strain varicella zoster infection to other healthy children and adults. However, immune compromised persons are at special risk for contracting vaccine strain chickenpox infections and suffering complications.

Generally, it is advised that persons recently given chickenpox vaccine avoid close contact for at least six weeks after vaccination with potentially susceptible persons, such as immune compromised persons, pregnant women, newborn infants and premature babies, especially if a rash develops after vaccination.”

Why are live virus vaccines still being used?

With documented cases of live virus vaccines contributing to vaccine strain virus shedding and transmission, it’s clear there remain many questions about their safety and effectiveness. Yet, their use continues, in part because the immune response triggered by live virus vaccines is considered to be superior to that triggered by inactivated vaccines.

In short, live virus vaccines tend to stimulate an immune response that’s more similar to one that would occur had you been exposed to the wild-type virus naturally. That being said, live virus vaccines rarely confer the same kind of longer lasting immunity that exposure to a naturally acquired infection can confer.

This is why booster shots are necessary, and why some have recommended that a third MMR vaccine dose be added to the U.S. vaccine schedule.

At the very least, it’s important to be aware of the differences between attenuated live virus vaccines and inactivated vaccines, especially if you’re part of a vulnerable population, such as very young children, the elderly, pregnant and breastfeeding women and people with acute or chronic health problems or a compromised immune system.

For now, however, there remain many unanswered questions regarding live virus vaccines and their ultimate impact on public health. As Fisher explained:17

“The impact of vaccine-strain virus shedding infection and transmission on individual and public health is a question that deserves to be asked and more thoroughly examined by the scientific community. The fact that children and adults given live virus vaccines have the potential to pose a health risk to both unvaccinated and vaccinated close contacts should be part of the public conversation about vaccination.”

____________________

For more:  https://madisonarealymesupportgroup.com/2018/12/09/vaccines-likely-infected-with-retroviruses-linked-to-chronic-disease/

https://madisonarealymesupportgroup.com/2017/10/15/vaccines-and-retroviruses-a-whistleblower-reveals-what-the-government-is-hiding/

https://madisonarealymesupportgroup.com/2018/03/01/vaccines-could-contribute-to-disease-epidemics-due-to-retrovirus-contamination/

https://madisonarealymesupportgroup.com/2018/06/23/the-role-of-retroviruses-in-chronic-illness-a-clinicians-perspective/

https://madisonarealymesupportgroup.com/2019/07/02/polio-like-manifestation-of-powassan-virus-with-anterior-horn-cell-involvement-canada/

https://madisonarealymesupportgroup.com/2019/06/15/therapeutic-efficacy-of-favipiravir-against-bourbon-virus-in-mice/

https://madisonarealymesupportgroup.com/2018/05/23/cdc-warns-about-7-new-tick-viruses/

https://madisonarealymesupportgroup.com/2018/12/04/is-the-chickenpox-vaccine-creating-a-shingles-epidemic/

https://articles.mercola.com/sites/articles/archive/2012/07/30/whooping-cough-vaccine.aspx  (Outbreaks of Whooping Cough related to pertussis vaccine)
https://ohioamf.org/wp-content/uploads/2015/11/HIGHLY-and-FULLY-VACCINATED-outbreaks.-1.pdf  (9 pages showing outbreaks in fully vaccinated populations)

 

 

Category:

vaccines, Viruses

Vaccine For Inflammation in the Works

https://thevaccinereaction.org/2019/08/vaccine-for-inflammation-in-the-works/

Vaccine for Inflammation in the Works

STORY HIGHLIGHTS

  • Scientists are working on a vaccine for autoimmune, inflammation-induced mental health issues using soil-derived bacteria.
  • Vaccines have been implicated in increasing the risk for neuropsychiatric issues in children.
  • Vaccines and all other immune-system activators act by provoking an inflammatory response.

Christopher Lowry, PhD and a team of researchers from the University of Colorado at Boulder are working on a vaccine to prevent inflammation-induced mental illness.1 The scientists are working with Mycobacterium vaccae, bacteria found in soil that has demonstrated anti-inflammatory properties in animal subjects. The U.S. Food and Drug Administration has not yet approved human trials, but Dr. Lowry hopes to create a vaccine for inflammation-induced mental health issues.

A number of neuropsychiatric issues have been linked to vaccination. A pilot study by scientists from Yale University and Pennsylvania State University, for example, showed that children who had received a flu vaccine had an 80 percent higher risk of being diagnosed with an eating disorder within three months compared with non-vaccinated controls. The risk for a obsessive-compulsive disorder was 23 to 27 percent higher three to 12 months following vaccination.2

Vaccination Produces Inflammation by Its Nature

The idea of vaccinating against inflammation may meet with challenges, as vaccination depends on inducing an inflammatory reaction as its mechanism of action. As explained by nephrologist Suzanne Humphries, MD,

“A vaccine by definition, causes repeated, chronic inflammation at set time intervals. Vaccines are designed to create peripheral inflammation…”3

The inflammatory response itself is crucial to any immune response, whether a natural trigger such as an infectious agent, an antigenic challenge, a physical stressor or vaccination. It is inflammation that signals the arrival of operatives of the immune system into the area of infection or damage, as indicated by the five “cardinal signs” of inflammation: redness, heat, pain, swelling, and loss of function.4

It is when the normal, healthy inflammatory response does not recede once the threat has been neutralized that inflammation may become chronic, resulting in any of over 100 potential autoimmune disorders including lupus, rheumatoid arthritis, psoriasis, Crohn’s disease and fibromyalgia to name just a few.5

Vaccination of patients with immune-mediated inflammatory diseases (IMIDs) can be problematic. Typically, anti-inflammatory therapies not only blunt the inflammatory reaction necessary for a vaccine response but also increase the likelihood of patients developing infectious diseases.6 Some concern has also been expressed that vaccination itself could act as a trigger for autoimmune disorders.7

According to immunologist and diabetes researcher Barthelow Classen, MD, the inflammatory responses generated by repeated vaccinations can and do produce the chronic inflammation and immune system overload that can lead to some of the more prevalent autoimmune disorders seen in today’s children.8 He adds that most patients do not even realize that they are suffering from the adverse effects of vaccines.

“Chronic inflammation is a serious health problem in the U.S. and around the world and all potential root causes should be fully investigated, including vaccination,” noted journalist Rishma Parpia in a 2016 article in The Vaccine Reaction.9

To propose that an inflammation-mediated mental illness (or any inflammation-based disorder) could be prevented with a vaccine designed to stimulate further inflammation is certainly an interesting concept that merits careful study.

References:

1 Kommers A-M. 5 Things To Know About A Potential Vaccine To Fight Mental Illness. Becker Hospital Review July 16, 2019.
2 McGovern C. Vaccination May Increase Risk of Rare Psychiatric Childhood Disorders, Study Finds. The Vaccine Reaction Feb. 13, 2017.
3 Humphries S. Vaccination. DrSuzanne.net.
4 Clem AS. Fundamentals of Vaccine Immunology. J Glob Infect Dis January-March 2011.
5 Autoimmune Disease List. American Autoimmune Related Diseases Association 2019.
6 Rahier J-F, et al. Vaccinations in Patients with Immune-mediated Inflammatory Diseases. Rheumatology 2010.
7 Hammoudi DA-S et al. Induction of Autoimmune Diseases Following Vaccinations: A Review. SM Vaccine Vaccin 2015; 1(3): 1011.
8 Classen JB. Review of Vaccine Induced Immune Overload and the Resulting Epidemics of Type 1 Diabetes and Metabolic Syndrome, Emphasis on Explaining the Recent Accelerations in the Risk of Prediabetes and other Immune Mediated Diseases. Journal of Molecular and Genetic Medicine 2014; S1:-025.
9 Parpia R. Inflammation: The Good and the Bad. The Vaccine Reaction Mar. 23, 2016.

_________________

For more:  https://madisonarealymesupportgroup.com/2018/10/08/vaccine-safety-efficacy-studies-that-are-the-bases-for-marketing-authorizations-are-a-complete-methodological-mess/

https://madisonarealymesupportgroup.com/2017/11/28/biological-mechanisms-of-vaccine-injury/

https://madisonarealymesupportgroup.com/2017/12/06/mechanisms-of-vaccine-injury-part-2/

https://madisonarealymesupportgroup.com/2019/07/23/lyme-disease-vaccines-past-future/

https://madisonarealymesupportgroup.com/2017/09/21/aluminum-flawed-assumptions-fueling-autoimmune-disease-and-lyme/

https://madisonarealymesupportgroup.com/2018/06/01/immunoexcitotoxicity-as-the-central-mechanism-of-etiopathology-treatment-of-autism-spectrum-disorders-a-possible-role-of-fluoride-aluminum/

https://madisonarealymesupportgroup.com/2018/09/28/toxic-metal-pollution-linked-with-development-of-autism-spectrum-disorder/

Category:

Activism, vaccines

Vaccine Informed Consent Press Conference

Vaccine Informed Consent Press Conference

Published on Apr 30, 2019

A news conference that calls attention to Pennsylvania House Bill 286, also known as the Informed Consent Protection Act. It would bar doctors from denying care to children whose parents have chosen not to vaccinate them.
Dr. Moss, an expert on medical ethics speaks first.
  • Doctors are refusing to treat children who are not vaccinating their children exactly as they say.  Moss states this is a return to “Paternalism,” where doctors are forcing their opinions upon parents of children. They are coercing parents into vaccinating their children against their better judgment.
Attorney Mary Holland speaks next and is a faculty member of NYU School of Law. She’s written two books on vaccines. She also has a vaccine injured child.
  • Holland states that it is a form of discrimination when parents are ostracized for departing from the orthodoxy of vaccine schedules. History has shown that when the right of informed consent is denied, it leads to very dark places: concentration camps, & experimentation on disabled children, African Americans, & Jews. She also states that, “fear of contagion is not a basis for rational discrimination.”
Dr. James Lyons-Weiler is a biomedical research scientist and has written three books. He runs IPAK (Institute for Pure and Applied Knowledge) is a not-for-profit organization which exists to perform scientific research in the public interest. It is registered with the State of Pennsylvania as a not-for-profit pure public charity.
  • Weiler points out that safety studies on vaccines remove those at risk for the very adverse reactions the study is looking for. He reminds us that there’s never been a single randomized prospective double-blind placebo controlled clinical trial to answer the question, “What if we vaccinated some people and not others?” He states it’s the most important question that could be asked. IPAK is conducting a vaccinated vs. unvaccinated study.

For more:  https://madisonarealymesupportgroup.com/2019/04/23/texas-bill-would-increase-vaccine-safety-reject-federal-narrative/

https://madisonarealymesupportgroup.com/2018/10/08/vaccine-safety-efficacy-studies-that-are-the-bases-for-marketing-authorizations-are-a-complete-methodological-mess/

https://madisonarealymesupportgroup.com/2018/03/21/congress-receives-vaccine-safety-project-details-since-the-cdc-fda-ignore-their-own-data-and-proclaim-vaccines-do-not-cause-autism/

https://madisonarealymesupportgroup.com/2019/06/13/blast-from-the-past-cdc-vaccine-authors-destroy-evidence-of-vaccine-harm/

FYI:  Every single Lyme/MSIDS patient I know that got vaccinated suffered a relapse of symptoms.

Category:

Activism, vaccines

Pharmaceutical Fraud & The Hidden Side of Clinical Trials

 Approx. 17 Min

Published on Jul 12, 2019

A case study in corporate malfeasance. References available at: tinyurl.com/y3mrknxq
The story I’m going to tell today begins just before the turn of the century. The year is 1999 and Merck has brought a new pain killer onto the market called Vioxx. According to a paper published in the British Medical Journal, since the early development of Vioxx some scientists at Merck were concerned that the drug might adversely affect the cardiovascular system. Despite Merck’s knowledge that Vioxx might increase blot clot formation, none of the intervention studies it did for the FDA in 1998 were designed to evaluate cardiovascular risk. So let’s think about this for a minute. Merck’s own scientists, while developing this new drug, say this could be bad for the heart, it could be bad for the cardiovascular system. So Merck made the decision to NOT evaluate the cardiovascular risk of that drug in its new drug application to the FDA. And let’s see how that turned out.
 Approx. 13 Min.

TEDx Talks

Published on Sep 28, 2016
Around half of the clinical trials done on medicines we use today are not published. A tragic truth that needs to be changed, to help doctors do their job properly and to not betray the trust of all those who have volunteered to be part of those trials. Find out more about the AllTrials campaign ad references for claims made in the talk at www.AllTrials.net. In particular, read more about the claim that around half of all clinical trials on the medicines we use today have not published results here http://www.alltrials.net/wp-content/u…. Audiovisual producer: Daniel Goldmann. Editing: Xavi Fortino. Film team: Elena Salcedo, Josep Fernández, Daniel Davidson, Nicolás Mazzini, Nacho Valentín, David Ramos, Ignacio Fuentes and Fran Rubio. Síle Lane is director of campaigns and policy at Sense about Science, a charity concerned with the use and abuse of scientific evidence in public life. Síle helps run the global AllTrials campaign for clinical trial transparency which is supported by thousands of people and organizations worldwide.
https://madisonarealymesupportgroup.com/2018/08/24/financial-kickbacks-for-vaccinations-abusive-illegal-fraudulent/  “This brings us to the financial incentives to pediatricians offered by insurance companies for vaccinating our children. The Blue Cross Blue Shield health insurance document explaining these financial incentives can be found here:  https://jeffreydachmd.com/wp-content/uploads/2018/08/Pediatricians-Receive-Financial-Incentives-Kickbacks-to-Vaccinate-Children-BCBS-2016-Booklet.pdf  Pediatricians are raking in 40-80 thousand dollars a year from these kickback schemes.”

Category:

Activism, research, vaccines